Berliner Centrum Fur Reise Und Tropenmedizin GmbH

At Berliner Centrum Fur Reise Und Tropenmedizin GmbH, clinical research in respiratory infections and viral diseases focuses on protecting older adults from common and serious infections such as influenza and respiratory syncytial virus.

• Testing new vaccines designed to prevent influenza illness and support better protection in adults.
• Evaluating approaches for RSV and human metapneumovirus to reduce lower respiratory tract disease.
• Assessing immune response and safety in studies that aim to improve prevention of seasonal respiratory infections.

These trials are centered on vaccine effectiveness, immune response, and infection prevention in populations at higher risk of complications.

This site also supports research in cytomegalovirus infection, with studies aimed at preventing primary infection and understanding how well candidate vaccines are tolerated and recognized by the immune system.

• Studying a vaccine approach to help prevent CMV infection in seronegative women.
• Monitoring safety and immunogenicity to see how well the body responds to the vaccine.
• Generating evidence to support future strategies for reducing congenital CMV risk.

The research at this Berlin clinic combines infectious disease expertise with practical prevention goals, especially for viruses that can cause significant illness across different age groups.